EMA CHMP has recommended the following for approval: Fylrevy, Ilumira, Kayshild, Kygevvi, Supemtek & Rezurock.

The EMA's recommendation for the approval of multiple drugs, including Fylrevy and Ilumira, signals potential growth opportunities for Sanofi and other pharmaceutical companies involved, underscoring the regulatory momentum in the sector.

Newsquawk StaffPublished On the live feed at 9 more headlines followed before this page went public
Newsquawk headlinesUTC

Iranian Foreign Minister Araqchi says they are prepared for both war and diplomacy, will respond more and more broadly to any aggression. Contacts continue with regional allies, are optimistic.

US President Trump nominates Kevin Warsh as Fed Chair

EMA CHMP has recommended the following for approval: Fylrevy, Ilumira, Kayshild, Kygevvi, Supemtek & Rezurock.

Iranian Foreign Minister Araqchi says they are prepared to return to talks with the US, on the condition they are based on mutual respect. The US' attitude is contradictory. Not seeking nuclear weapons.

ExxonMobil (XOM) Q4 2025 (USD): adj. EPS 1.71 (exp. 1.70), Revenue 82.3bln (exp. 80.67bln)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Recommended an extension on Zynyz. Positive option to extend Eurneffy. and seven other extensions for: Akeega, Efmody, Iclusig, Imfinzi, Kerendia, Noxafil and Opdivo.
Context

This could lead to positive sentiment in equities within the biotechnology and life sciences space, particularly as investors assess the implications for future revenues and competitive positioning.

Related headlines

The whole workspace, free to try.

Try it free